These findings suggested that MBL2 SNP rs7096206 is associated with increased HCC risk in a hepatitis-free population and that it has the potential to serve as a biomarker for detecting populations at increased HCC risk. The gene discussed is MBL2; the disease is hepatocellular carcinoma.